Consensus EPS · Q4 2026
$0.52
Consensus revenue · Q4 2026
$314.7M
Analysts
8
Expected report
Aug 5, 2026
What to watch
- Analyst ratings: Downgrades trending
Analyst consensus
Based on estimates from 8 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $311.6M | $314.7M | $317.9M |
| EPS | $0.51 | $0.52 | $0.53 |
| EBITDA | $92.3M | $93.9M | $97.6M |
| EBIT | $63.4M | $64.6M | $67.1M |
| Net income | $79.9M | $81.5M | $83.1M |
- Revenue$314.7M
- EPS$0.52
- EBITDA$93.9M
- EBIT$64.6M
- Net income$81.5M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q3 2026 | $311.4M | $316.1M | -1.5% | $0.53 | $0.53 | -0.8% |
- Q3 2026-1.5%-0.8%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $308M | $318.1M | — | — | -3.2% |
| EPS | $0.48 | $0.50 | — | — | -4.4% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Bio-Techne (TECH) Q4 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $50.00
- Consensus
- $66.44
- Median
- $73.00
- High
- $79.00
- Current
- $72.14
- Upside
- -7.9%
Upside calculated vs most recent trading price of $72.14.
Analyst ratings
Consensus: Buy — based on 26 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 9, 2026 | RBC Capital | downgrade | Outperform | Sector Perform |
| Jun 30, 2026 | TD Cowen | downgrade | Buy | Hold |
| Jun 30, 2026 | Benchmark | downgrade | Buy | Hold |
| Jun 29, 2026 | Citigroup | downgrade | Buy | Neutral |
| Jun 26, 2026 | William Blair | downgrade | Outperform | Market Perform |
| Jun 26, 2026 | Stephens & Co. | downgrade | Overweight | Equal Weight |
| Jun 26, 2026 | Baird | maintain | Neutral | Neutral |
| May 7, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| May 7, 2026 | Evercore ISI Group | maintain | In Line | In Line |
| May 7, 2026 | Citigroup | maintain | Buy | Buy |
- Jul 9, 2026RBC CapitalSector Perform
- Jun 30, 2026TD CowenHold
- Jun 30, 2026BenchmarkHold
- Jun 29, 2026CitigroupNeutral
- Jun 26, 2026William BlairMarket Perform
- Jun 26, 2026Stephens & Co.Equal Weight
- Jun 26, 2026BairdNeutral
- May 7, 2026Wells FargoOverweight
- May 7, 2026Evercore ISI GroupIn Line
- May 7, 2026CitigroupBuy
Frequently asked questions
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.23% TTM
- Dividend Profile0.44% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.